MBX Biosciences Inc. Comm...

NASDAQ: MBX · Real-Time Price · USD
14.74
1.53 (11.58%)
At close: Aug 15, 2025, 3:59 PM
14.92
1.22%
After-hours: Aug 15, 2025, 07:58 PM EDT

MBX Biosciences Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
49.35M 30.52M 24.21M
Short-Term Investments
212.8M 50.15M 18.25M
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
50K 50K 42K
Receivables
682K 208K 142K
Inventory
n/a n/a n/a
Other Current Assets
803K 133K 84K
Total Current Assets
267.29M 83.47M 44.21M
Property-Plant & Equipment
1.2M 665K 842K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
1.25M 715K 884K
Total Assets
268.54M 84.18M 45.09M
Account Payables
5.33M 1.39M 976K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
171K 153K 137K
Other Current Liabilities
2.15M 1.21M 996K
Total Current Liabilities
11.05M 3.93M 3.43M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
42K 152.55M 83.94M
Total Long-Term Liabilities
42K 152.72M 84.27M
Total Liabilities
11.09M 156.65M 87.7M
Total Debt
171K 324K 461K
Common Stock
5K 1K 1K
Retained Earnings
-137.5M -75.58M -43.02M
Comprehensive Income
55K 60K 3K
Shareholders Equity
257.44M -72.47M -42.6M
Total Investments
212.8M 50.15M 18.25M